Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
Articles 1 - 3 of 3
Full-Text Articles in Law
Credible: Why We Doubt Accusers And Protect Abusers: A Book Talk With Author Deborah Tuerkheimer, Deborah Tuerkheimer, Emily Sack
Credible: Why We Doubt Accusers And Protect Abusers: A Book Talk With Author Deborah Tuerkheimer, Deborah Tuerkheimer, Emily Sack
School of Law Conferences, Lectures & Events
No abstract provided.
10-50: Addiction And Confinement In Whatcom County, Kaitlyn Davidson
10-50: Addiction And Confinement In Whatcom County, Kaitlyn Davidson
WWU Honors College Senior Projects
Researching the failures and successes of the criminal justice system leads to numbers, not lives.
What drove me to this research was my internship with the Whatcom County Public Defender’s Office, where I interacted with detainees on a daily basis. The narrative power of their stories was enough to make me question the role that jails should play in our community’s response to substance abuse. None of those stories have been included.
It is easy to paint horrifying portraits of inmates rotting in prisons, brutalized by a system designed to torment them. But this is not reality. It is comfortable …
When Desperate Patients Go To Court For Unproven Treatments - The Battle For Hospital Independence, Christopher Robertson, Margaret Houtz
When Desperate Patients Go To Court For Unproven Treatments - The Battle For Hospital Independence, Christopher Robertson, Margaret Houtz
Faculty Scholarship
As the Covid-19 pandemic wears on, patients have asked courts to compel hospitals to administer unproven therapies, with mixed legal results. Although talk radio hosts, politicians, and social media users have promoted various treatment approaches, they have given particular attention to ivermectin. The Food and Drug Administration (FDA) has approved ivermectin for use in humans for treating onchocerciasis (river blindness), intestinal strongyloidiasis, certain other parasitic worms, head lice, and skin conditions such as rosacea. Although this approval facilitates legal offlabel use for prophylaxis against or treatment of other conditions, both the FDA and the Centers for Disease Control and Prevention …